Condition: Coronary Artery Disease · Sponsor: Orchestra BioMed, Inc
A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR).
This description comes directly from the study's public registry record.
Hans-Peter Stoll, MD, PHD · 646-956-2161 · hpstoll@orchestrabiomed.com
Amy Berman, MPH · aberman@orchestrabiomed.com
Always discuss trial participation with your own doctor first.
| The Cardiac and Vascular Institute | Gainesville, Florida, United States | Recruiting |
| Ascension Sacred Heart | Pensacola, Florida, United States | Recruiting |
| Ascension St. Vincent | Indianapolis, Indiana, United States | Recruiting |
| Ascension Via Christi Saint Francis | Wichita, Kansas, United States | Recruiting |
| Ascension Saint Agnes Heart Care | Baltimore, Maryland, United States | Recruiting |
| Corewell Health William Beaumont University Hospital | Royal Oak, Michigan, United States | Recruiting |
| St. Francis Hospital | Roslyn, New York, United States | Recruiting |
| Mission Hospital | Asheville, North Carolina, United States | Recruiting |
| The Lindner Center for Research at Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| Thomas Jefferson University | Philadelphia, Pennsylvania, United States | Recruiting |
| WellSpan Health | York, Pennsylvania, United States | Recruiting |
| TriStar Centennial Medical Center | Nashville, Tennessee, United States | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07045194